IJH Volume 124, Issue 2, August 2026 is now available.
IJH Volume 124, Issue 2, August 2026 is now available.
JSH members can access the full text.
-
- Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan
- Renal recovery and clinical outcomes with daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma with severe renal impairment